News archive


Elekta’s Esteya electronic brachytherapy system featured on news station in Phoenix

In the U.S., August was “Sun Safety Month.” To bring awareness to this, a news station in Phoenix, Arizona featured Dr. Gerrit Henry and Suzanne Williams, a patient who recently received electronic brachytherapy at Arcadia...[more]


The Netherlands’ Radiotherapy Group treats skin cancer patients with Esteya electronic brachytherapy

On June 14, Radiotherapy Group clinicians in Deventer, the Netherlands used their Esteya® electronic brachytherapy system for the first time to treat a female patient in her late fifties with two basal cell carcinomas next to her...[more]


The Netherlands’ Radiotherapy Group is country’s first to use Elekta’s Esteya electronic brachytherapy to treat skin cancer patients

On March 3, Radiotherapy Group clinicians at Ziekenhuis Gelderse Vallei (Ede, the Netherlands) used their Esteya® electronic brachytherapy system for the first time to treat a 73-year-old male patient with a nodular basal cell...[more]


Researchers present one-year follow-up data of Esteya® electronic brachytherapy for basal cell carcinoma

Hospital La Fe clinicians using Esteya skin cancer system achieve complete response among 90 and 95 percent of patients[more]


Florida’s Lynn Cancer Institute begins treating skin cancer patients with Elekta’s Esteya electronic brachytherapy system

BOCA RATON, Oct. 14 – With the recent treatment of a 65-year-old woman with a skin cancer lesion on her chin, Lynn Cancer Institute of Boca Raton Regional Hospital launched a new therapy program for patients with basal cell or...[more]


Researchers demonstrate effective treatment and outstanding cosmetic outcome of Elekta electronic brachytherapy for skin cancer

Hospital La Fe clinicians using Esteya® system achieve complete response among 100 percent of patients[more]


Boca first in state with latest care for skin cancer — brachytherapy

The Lynn Cancer Institute at Boca Raton Regional Hospital has become the first facility in Florida (and one of just a handful nationwide) to offer skin-cancer sufferers treatment via the FDA-approved Esteya — a non-invasive...[more]

Category: general


Esteya at Annual Meeting of American Academy of Dermatology (AAD)

Elekta will show Esteya electronic brachytherapy at the upcoming Annual Meeting of American Academy of Dermatology (AAD), March 20-24, in the Moscone Center, San Francisco, CA. The AAD show is one of the largest dermatology...[more]


Sun eBx adds Esteya to its treatment offering for skin cancer

Sun eBx, a dermatology/radiation oncology healthcare provider in Phoenix, Arizona, is pleased to offer a new service to its clients.  Sun eBx recently purchased Esteya®, an electronic brachytherapy system that will be...[more]


Leading edge workshop for skin brachytherapy in Manchester features Esteya

An expert faculty from The Christie, Manchester and Hospital La Fe, Valencia, will share their Esteya expertise in the workshop ‘HDR and electronic brachytherapy for skin cancer’ that will take place at The Christie Education...[more]


New Esteya case report University Polytechnic Hospital La Fe, Valencia

Esteya electronic brachytherapy is a new approach for high precision skin cancer treatment that can be used in dermatology clinics and radiotherapy departments. This case report describes the Esteya treatment of a 67-year-old...[more]


Florida clinic set to begin skin cancer treatments with Esteya electronic brachytherapy early next year

Lynn Cancer Institute of Boca Raton Regional Hospital, Florida is preparing to use its recently purchased Esteya® electronic brachytherapy system for the first time to treat skin cancer patients. [more]


As seen in Wavelength:

First US patients receive Esteya® electronic brachytherapy[more]


Esteya® takes on Europe!

After its successful introduction in the USA, Esteya is now finding its way into Europe with first patients being treated in Spain. More and more clinics show their interest in the new approach to treating skin cancer and the...[more]


First US patients receive Esteya electronic brachytherapy for skin cancer

Patient-friendly treatment helps minimize radiation exposure to healthy tissues[more]


Esteya to be exhibited at the 23rd Annual Scientific Meeting of the Australasian Brachytherapy Group

The 23rd Annual Scientific Meeting of the ABG will be held from 20 - 22 February 2014.On Thursday February 20th a special workshop “Skin and Surface Brachytherapy” is organised by Nucletron, an Elekta company. The workshop will...[more]


Nucletron, an Elekta company installs Esteya for treating skin cancer in major U.S. center

NEW YORK, Dec. 13 /PRNewswire/ – The first Esteya® electronic brachytherapy system in the United States has been installed at New York’s Memorial Sloan-Kettering Cancer Center. Esteya by Nucletron, an Elekta company, is a new...[more]


Hospital in Spain First to Treat Skin Cancer Patients with Esteya Electronic Brachytherapy System

Hospital La Fe’s study demonstrates user- and patient-friendliness and short procedure time with Esteya[more]


Esteya receives GIO award 2013

On Saturday October 12th, an independent jury awarded Esteya with a GIO award, the Dutch recognition for Good Industrial Design (GIO).The jury reviewed 60 submissions and felt that Esteya meets all the assessment criteria:...[more]


Nucletron, an Elekta Company, Receives U.S. FDA 510(k) Clearance for Esteya Electronic Brachytherapy System for Treating Skin Cancer

ATLANTA, Oct. 2,2013 /PRNewswire/ – Esteya®, an electronic brachytherapy system, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), enabling medical centers in the United States to offer their...[more]


Nucletron, an Elekta Company, Introduces Esteya, Electronic Brachytherapy for Treating Skin Cancer

Nucletron, an Elekta company, and the world leader in brachytherapy, has launched Esteya®, a new approach for treating patients with skin cancer. [more]


Hospital Universitari Politècnic La Fe, Valencia, Spain first in Europe to install Esteya

The first installation of Esteya in Europe has taken place in La Fe, Valencia, Spain. Their first patient is expected to be treated with Esteya during fall 2013. La Fe is one of the European clinical research sites for Esteya. [more]


Esteya receives CE-mark

Nucletron, an Elekta company has received CE marking for Esteya, a new approach for high precision skin cancer treatments. Clinics will have access to a safe and patient-friendly treatment and are able to expand radiation therapy...[more]